drugset / Trial / NCT00981318
Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
NaSingle-groupOpen-labelTreatment
Summary
This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no nucleoside medications) in HIV patients failing their initial antiviral therapy.
Timeline
- Start
- 2009-12
- Primary completion
- 2015-05
- Completion
- 2015-05
Outcome
Outcome not reported
Stopped (Enrollment): “unable to enroll expected number of subjects”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | 400 mg | — |
| Subject | Maraviroc | Other / unclassified | 150 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |